PORT WASHINGTON, NY – July 24, 2018: Pall Corporation, a global leader in filtration, separation and purification, is partnering with BioSciencesCorp, a consulting company providing novel biologics and biosimilars process know-how and regulatory experience from molecule selection to full commercialization. Together they will deliver cost-effective manufacturing strategies, and efficient upstream and downstream process equipment and facility design solutions for manufacturers.

“We are excited to partner with BioSciencesCorp to provide enabling technologies and services that support their customers mission-critical projects,” said Mario Philips, VP & General Manager at Pall Biotech. “Together, we can provide total solutions that today’s drug manufacturers need and make an impact where it matters most: with the patient.”

Leveraging deep industry expertise, the BioSciencesCorp team aligns with customers at all phases of the process from concept to commercialization. Customers benefit from small-company style, speed, and service and support from the initial modeling phases through implementation. The team is also available to help with critical aspects of process integrity, such as quality by design, process analytic technologies, and regulatory guidance.

“Starting from feasibility phases through to transfer and training activities, BioSciencesCorp was built to offer quality guidance and support to each customer,” said Daniel Chang, Executive Director and Founder of BioSciencesCorp. “Aligning with Pall Biotech deepens our ability to provide truly end-to-end, integrated solutions to customers from consultation through to clinical development and commercial manufacturing.”

This strategic partnership provides drug manufacturers with direct access to Pall Biotech bioreactors, mixing and storage product lines, single-use downstream technologies, consumables, and inter-unit operation connections. Regardless of the type of project, customers also have the option to work with Pall service teams throughout process design and development to ensure process success.


About Pall Corporation

Pall Corporation is a filtration, separation and purification leader, providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit www.pall.com

Or follow us on social media: YouTube -   LinkedIn - Twitter - Facebook


About BioSciencesCorp

BioSciencesCorp provides unique end-to-end biologics solutions driven by detail. Our multi-faceted team has deep experience in creating initial concepts, modeling capacity and scheduling, selection of engineering firms, and implementing proper quality by design concepts so that your team can successfully and efficiently bring biologics and biosimilars products to market. BioSciencesCorp and its affiliates offer small company speed complemented by expertise from molecule selection to full commercialization and can help at every stage of development.

For more information visit www.biosciencescorp.com or consult directly with BioSciencesCorp by reaching out to Daniel Chang via email: daniel.chang@biosciencescorp.com

Pall Corporate Media Contact

Pall Corporation

Mariann Kourafas

Director of Communications


Media Contact

White Matter Communications

Beth Willers



더 Biotech Press Releases
Read all the latest news and developments from Pall and keep in touch with industry trends and opinion.
April 2020
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.